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Background: The Ste20-like kinase, SLK, plays an important role in cell proliferation and cytoskeletal remodeling. In
fibroblasts, SLK has been shown to respond to FAK/Src signaling and regulate focal adhesion turnover through Paxillin
phosphorylation. Full-length SLK has also been shown to be essential for embryonic development. In myoblasts, the
overexpression of a dominant negative SLK is sufficient to block myoblast fusion.
Methods: In this study, we crossed the Myf5-Cre mouse model with our conditional SLK knockout model to delete
SLK in skeletal muscle. A thorough analysis of skeletal muscle tissue was undertaken in order to identify defects
in muscle development caused by the lack of SLK. Isometric force analysis was performed on adult knockout
mice and compared to age-matched wild-type mice. Furthermore, cardiotoxin injections were performed followed by
immunohistochemistry for myogenic markers to assess the efficiency muscle regeneration following SLK deletion.
Results: We show here that early deletion of SLK from the myogenic lineage does not markedly impair skeletal muscle
development but delays the regenerative process. Interestingly, adult mice (~6 months) display an increase in the
proportion of central nuclei and increased p38 activation. Furthermore, mice as young as 3 months old present with
decreased force generation, suggesting that the loss of SLK impairs myofiber stability and function. Assessment
of structural components revealed aberrant localization of focal adhesion proteins, such as FAK and paxillin.
Our data show that the loss of SLK results in unstable myofibers resulting in a progressive myopathy. Additionally, the
loss of SLK resulted in a delay in muscle regeneration following cardiotoxin injections.
Conclusions: Our results show that SLK is dispensable for muscle development and regeneration but is required for
myofiber stability and optimal force generation.
Keywords: Ste20-like kinase, Myofiber stability, Muscle regenerationBackground
Attachment of myofibers to the extracellular matrix (ECM)
is essential for myofiber integrity and muscle function.
These attachments are mediated by membrane-associated
protein complexes. These complexes also attach to intracel-
lular proteins that mediate myofiber stability through con-
nections to the cytoskeleton. Two distinct protein families
mediate attachment to the ECM, the dystrophin-associated* Correspondence: lsabourin@ohri.ca
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sion family of proteins [1]. The DGC associates with the
ECM through its interaction with the extracellular protein
laminin [2, 3]. The loss of several components of the DGC
leads to the generation of severe myopathies, the most
notable of which is the loss of functional dystrophin, which
is the underlying cause of Duchenne muscular dystrophy
(DMD) [4]. The alternative attachment system consists of
integrin subunits and their associated proteins [1, 5]. Integ-
rin complexes are crucial components of cell-cell and cell-
ECM attachments in multiple tissues throughout the body
including skeletal muscles [6]. Similar to its binding to the
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plexes are primarily comprised of heterodimers of α7 and
β1 subunits [1]. Muscle-specific deletion of the β1 subunit
results in decreased myoblast fusion and severe defects in
sarcomere assembly [8]. The loss of functional α7 integrin
has been identified as a cause of muscular dystrophy in
human patients [9, 10]. Interestingly, α7 integrin has been
demonstrated to act as a compensatory mechanism for the
loss of dystrophin in DMD animal models [11]. Conversely,
ablation of α7 integrin in Mdx mice results in a more
severe phenotype than the dystrophin knockout alone and
better reproduces the clinical progression of DMD [12].
The integrin complexes also have an essential role in
forming the attachment of the tendon and muscle, termed
the myotendinous junction (MTJ) [13, 14].
Networks of intracellular complexes form the costamere
which attaches membrane proteins to the cytoskeleton
[15]. The function of the costamere is to transmit forces
laterally from the sarcolemma to the sarcomere as well as
to stabilize the intracellular myofiber structure. Down-
stream components of the integrin signaling system have
been found to be vital for the formation of costameres and,
similar to the DGC and integrins, loss of proteins within
these complexes have a severe impact on muscle integrity.
For example, skeletal muscle deletion of integrin associating
protein Talin results in decreased force generation as well
as a central nuclear myopathy in mice [16–18]. Addition-
ally, focal adhesion kinase (FAK) was found to be essential
for the formation of costamere rings and the fusion of
myoblasts into multi-nucleated myotubes [19, 20]. Inter-
estingly, downstream components of the integrin signaling
system, such as FAK and paxillin, are also upregulated in
hypertrophied muscles, suggesting that they are beneficial
for muscle growth and function [21].
The Ste20-like kinase (SLK) is a ubiquitously expressed
protein found at high levels in developing myogenic and
neuronal tissues [22, 23]. Full-length SLK consists of an
N-terminal catalytic kinase domain, a coiled-coiled region
and a disorganized C-terminal region termed the ATH
domain [24, 25]. The ATH region has been shown to bind
Ldb1 and LMO4, both of which act to modulate SLK
kinase activity [26, 27]. We have shown that SLK is
activated downstream of the integrin/FAK/Src signaling
system to mediate cellular migration and focal adhesion
turnover through paxillin phosphorylation [28, 29]. SLK
also functions upstream of RhoA-GTPase to regulate the
formation actin stress fibers in smooth muscle cells [30].
Expression of a dominant negative SLK leads to cell cycle
arrest, likely due to its ability to control cytoskeletal
remodeling at mitotic entry [31, 32]. Supporting this, a
role for SLK in microtubule radial organization and Golgi
orientation has been demonstrated [33, 34]. Our previous
data have shown that SLK is also expressed in mature
muscle and co-localizes with Z-band proteins, such as α-actinin. SLK was also found to be preferentially expressed
in type I and type IIA fibers in skeletal muscle [23]. In
myoblasts, SLK has been demonstrated to be critical for
fusion and differentiation [23].
Recently, our analysis of an SLK gene trap model revealed
a significant reduction in myosin heavy chain (MyHC) and
MyoD+ populations in the developing myogenic compart-
ment, supporting a role for SLK in the development and
expansion of embryonic skeletal muscles [35]. However, it
is still unclear whether this was due to the observed defects
in placental angiogenesis, or as a direct result of SLK dele-
tion within the myogenic lineage. Interestingly, muscle-
specific expression of a dominant negative SLK driven off
the differentiation-specific human skeletal actin (HSA) pro-
moter resulted in viable mice with enhanced regeneration
and myoblast fusion [36].
To investigate the role of SLK during early muscle
development and in myoblasts, we performed a muscle
specific knockout using the Myf5-Cre knock-in mice
and a conditional SLK knockout allele. In contrast to the
gene trap model, muscle-specific deletion of SLK results
in viable mice with apparently normal myogenic compart-
ments in the embryo. However, adult knockout mice
present with a progressive myopathy and impaired muscle
function combined with a marked delay in regenerative
capacity. Structural analysis of knockout muscle tissues
showed a mislocalization of focal adhesion proteins at the
periphery of the myofibers. Collectively, these results
suggest that SLK is necessary for myofiber integrity and
maintenance but is dispensable for complete muscle re-
generation and embryonic myogenesis.
Methods
Animal care and genotyping
The SLK conditional allele was generated by the inser-
tion of the FRT-flanked Neo cassette downstream of
exon 2 with loxP sites flanking exons 2 to 6 of the
murine SLK locus. Chimeras were generated on a
mixed C57BL/129 background and germline pups in a
C57 background were mated with β actin-Flp recombinase
transgenic mice to obtain the floxed line (SLKfl/+).
Myf5Cre/+ mice (Myf5-Cre) were obtained from Jackson
Lab [37]. Genotyping was performed using ear clips from
3-week-old weanlings and processed using proteinase K
(QIAGEN, Mississauga, ON, Canada). Mice were geno-
typed based on primers designed flanking the 3′ SLK loxP
site. Wild type alleles produced a fragment at 437 bp,
whereas the loxP mutant generates a fragment of 471 bp.
Cre-positive animals were identified by genotyping for Cre
recombinase using sequence specific primers (Table 1).
Myf5-Cre mice were crossed to SLKfl/fl or SLKfl/+ mice to
obtain heterozygote, wild type and homozygote progenies.
Cre-mediated recombination at the SLK locus was
assessed by PCR analysis by introducing an additional
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recombined alleles (>5 kbp) are not amplified.
Western blotting
For Western blotting, skeletal muscles were frozen in li-
quid nitrogen and ground with a mortar and pestle.
Ground tissues were then lysed in RIPA buffer containing
protease and phosphatase inhibitors as previously de-
scribed [35]. Lysates were then cleared by centrifugation
at 14,000RPM for 5 min at 4 °C. Protein concentration
was determined by using Bradford protein assay dye re-
agent (Bio-Rad, Mississauga, ON, Canada). Equal amounts
of protein were run on polyacrylamide gels and transferred
onto polyvinylidene difluoride membranes (PVDF). Mem-
branes were probed with primary antibodies for 1 h at
room temperature, or overnight at 4 °C followed by
secondary HRP-conjugated antibodies for 1 h at room
temperature. Antibody detection was performed by chemi-
luminescence and X-ray film exposure.
Immunofluorescence and immunohistochemistry
Muscles for immunofluorescence were isolated by careful
dissection from the tendon, followed by either OCT em-
bedding and snap-freezing in isopentane/liquid nitrogen or
formalin-fixed overnight and paraffin embedded. Sections
(5 μm) were boiled in 10 mM citrate buffer for antigen re-
trieval followed by permeabilization for 30 min in 0.3%
Triton-X, rinsed in PBS, and incubated in primary antibody
overnight. Sections were then incubated for 1 h in secondary
antibody and washed in PBS. Slides were mounted in Anti-
fade reagent with DAPI to preserve staining and to identify
nuclei (ProLong Gold Antifade). Sections were processed
similarly for DAB staining, with an additional incubation in
3% H2O2 following antigen retrieval, and mounted in
Permount mounting media following dehydration.
Transmission electron microscopy
Muscle specimens were fixed in buffered 2.5% glutaralde-
hyde for 2 h, rinsed in 50 mM sodium cacodylate buffer,
and post-fixed for 90 min in aqueous 2% osmium tetroxide.
Following dehydration in an ethanol series and suspension
in acetone, specimens were embedded in Spurr’s resin and
polymerized at 65 °C overnight. Thin (80 nm) sections were
counter-stained with uranyl acetate and lead citrate andTable 1 Genotyping and recombination PCR primer sequences
5′ loxP forward SLK primer (5′F) TTGGGGGATGGCTTCGTGCTT
3′ loxP forward SLK primer (3′F) TGAGGACCTGGGGAGATTGCT
3′ LoxP reverse SLK primer (3′R) ATGCAGCTGTATCTTCACAAG
5′ Cre primer GGATTGCTTATAACACCCTGTTACG
3′ Cre primer TATTCGGATC ATCAGCTACACCAGAGobserved on a Hitachi H-7100 TEM. Images were captured
at the indicated magnifications.
Cardiotoxin injections
Muscle injury experiments were performed as previously
described [36]. Briefly, 10–12-week-old mice were anes-
thetized with buprenorphine according to Animal Care
and Veterinary Services (ACVS) uOttawa guidelines.
Tibialis anterior (TA) muscles were injected with 30 μL
of 10 μM cardiotoxin (CTX, Sigma-C9759). Contralateral
TA muscles were injected with a saline control. Muscles
were extracted at 7, 10, and 21 days post injection (DPI).
Cross-sectional area and minimum Feret’s diameter were
measured on random images of TA muscles stained with
H&E (ImageScope; Aperio, Vista, CA, USA).
Fiber size and central nuclei quantification
For quantification of fiber size, cross sections were stained
with hematoxylin and eosin. Cross-sectional areas were
calculated using Aperio Imaging software. For soleus
muscles, every observable fiber was measured (~50–100/
muscle). For TA muscles, fibers from 5 random fields of
view were quantified (~300–400 fibers/muscle). Fiber area
was then averaged for each muscle taken. Central nuclei
were counted from 5 random fields of view on cross sec-
tions for each muscle (5/genotype). Total number of fibers
with central nuclei from all fields of view was calculated
as a percentage of total fibers counted.
Antibodies
Our rabbit custom polyclonal antibodies for SLK was
used throughout this study, as previously described [35].
GAPDH (#5174), P-Y397-FAK (#3283), P-Y118-Paxillin
(#2541), P-p38 (#4511), p38 (#9212), P-S9-GSK3β
(#9336), GSK3β (#9315), P-SAPK/JNK (#4668), and
SAPK/JNK(#9252), were acquired from cell signaling.
MHC type 1/slow (M8421), MHC type 2/fast (M4276), γ
tubulin (T5192) and Vinculin (V9131) were purchased
from Sigma-Aldrich. Antibodies for dystrophin (ab15277)
and laminin (ab11575) from Abcam were used for stain-
ing. The Myf5 (sc-302) and Myogenin (sc-12732) anti-
bodies were purchased from Santa Cruz. Antibodies for
periostin (AF2955) and Pax7 (MAB1675) were from R&D
Systems. Finally, total FAK (610088) and total paxillin
(612405) were acquired from BD Biosciences.
Isometric contractile properties and statistical analysis
Mice were first injected with buprenorphine (i.p. 0.1 mg/
kg) and then anesthetized with pentobarbital sodium (i.p.
50 mg/kg) 15 min later [38]. The right soleus (Sol) and
extensor digitorum longus (EDL) muscles were dissected
and incubated in vitro in a buffered physiological salt solu-
tion (Krebs-Ringer) supplemented with glucose (2 mg/
mL) and a constant bubbling of carbogen (5% CO2, 95%
Pryce et al. Skeletal Muscle  (2017) 7:3 Page 4 of 13O2) at 25 °C. After 15 min of equilibration at optimal
length (L0), the following contractile properties were mea-
sured: time-to-peak twitch tension (TPT, ms) with 0.2 ms
square-wave pulses of supramaximal voltage (~25 V)
through two platinum electrodes, half-relaxation time (1/2
RT, ms), twitch tension (Pt, g) and maximum tetanic ten-
sion (P0, g) for 700 ms at frequencies of 10, 20, 50, 80,
100, and 120 Hz using the Dual-Mode Lever Arm System
305B-LR controlled by the Dynamic Muscle Control and
Data Acquisition software (Aurora Scientific Inc. Aurora,
Ontario, Canada) [39–41]. At the end of the contractile
properties measurements, tendons were removed and
muscles were weighed. The cross-sectional areas were es-
timated by dividing the wet weight by the optimal muscle
length multiplied by the muscle density (1.06 g/cm3)
multiplied by the fiber-to-muscle length ratio for Sol and
EDL muscles [42]. All values are expressed as means ± SE.
The data were analyzed by two-way ANOVA to determine
whether the variations among the experimental groups
were significant (InStat software, version 3). When a sig-
nificant F ratio was obtained, a posteriori test was per-
formed (Tukey’s protected least-significant difference test)
to determine whether there were any specific differences.
The level of significance was set at p < 0.05.
Primary myoblast extraction and in vitro differentiation
Primary myoblast cultures were isolated as previously
described [36]. Briefly, hind leg muscles from 6-week-old
mice were minced and digested in collagenase/dispase.
Cells were collected and grown in Ham’s F-10 media
(Sigma-Aldrich, St Louis, MO, USA). Medium was sup-
plemented with 10 ng/mL bFGF. When cultures reached
70%, density medium was switched to 2% horse serum
to induce differentiation. Cells were fixed 4 days after
medium changed and stained using MF20 or an anti-
Myogenin antibody. Fusion index was calculated as pre-
viously described [36].
Fiber isolation and imaging
Primary myofibers were isolated using established methods
[43]. Individual EDL muscles were carefully dissected from
mice of each genotype and placed in 0.2% collagenase type
1 and incubated at 37 °C. Muscles were periodically tritu-
rated in order to release individual fibers. Muscle fibers
were removed and fixed in 4% PFA followed by treatmentTable 2 Quantitative PCR primers
Forward primer
α7 integrin 5′-ACTGTCCGAGCCAATATCACC
β1 integrin 5′- CATCCCAATTGTAGCAGGCG-
β1D integrin 5′-CATCCCAATTGTAGCAGGCG-3
Dystrophin 5′-GTGGGAAGAAGTAGAGGACTG
GAPDH 5′CATCACCATCTTCCAGGAGCG-in 0.3% Triton X-100 in order to permeabilize the mem-
branes. Following immunostaining, images of fibers were
captured on LSM 510 META confocal microscope.
Quantitative reverse transcription-polymerase chain
reaction
Diaphragm muscle RNA was extracted using Trizol re-
agent and extraction protocol. RNA was then purified
using RNeasy kit (Qiagen). A total of 500 ng of RNA from
each sample was used in SuperScript first-strand cDNA
synthesis using oligiodT primers (Invitrogen). The indi-
cated targets were amplified using gene-specific primers
and SYBR Green Reagent (Bio-Rad). Reactions were car-
ried out on an Applied Bioscience 7500 Fast-Real-Time
PCR System. Sequences for α7 integrin, β1 integrin, β1D
integrin, and dystrophin are listed in Table 2 [20, 44, 45].
GAPDH was used as a reference sample.
Results
Generation of conditional SLK knockout model
SLK has been shown to be highly expressed in both the
myogenic and neuronal compartments of the developing
embryo [22, 23]. We have previously demonstrated a
role for SLK in muscle development using a transgenic
model in which dominant negative SLK (K63R) was
expressed in myogenic cells under the control of the
human skeletal actin (HSA) promoter [36]. To gain further
insights into the role of SLK in muscle development and
function, we generated a skeletal muscle-specific deletion of
SLK. A conditional SLK allele was generated by flanking
exons 3 and 6 of the murine SLK gene with loxP sites
(NM_001164639.1) (Fig. 1a). Breeding of SLKfl/fl mice
to β-actin-Cre resulted in no viable knockout progeny,
suggesting that global SLK deletion is embryonic lethal,
consistent with our previous findings from a gene trap
model (Additional file 1: Table S1) [35].
The muscle-specific SLK knockout was generated by
crossing the conditional SLK allele into the Myf5-Cre strain
[37]. Myf5 is expressed at 8.5 day post-coitum (dpc) in the
rostral somites and between days 10.5 and 12.5 dpc in the
developing limb buds, allowing for Cre expression and
deletion of SLK within the developing myogenic compart-
ments prior to myofiber formation [46, 47]. In stark
contrast to the global SLK knock out models, muscle-
specific deletion of SLK resulted in viable progeny at theReverse primer
GT-3′ 5′-ACCAGTAGTCCCGCCAGCACA-3′
3′ 5′-CGTGTCCCACTTGGCATTCAT-3′
′ 5′-GAGACCAGCTTTACGTCCATAG-3′
TT-3′ 5′-AGGTCTAGGAGGCGTTTTCC-3′
R′ 5′GAGGGGCCATCCACAGTCTTC-3′
Fig. 1 Skeletal muscle deletion of SLK. a Schematic representation of the SLK locus and the SLK-targeted allele showing the Frt (black arrowhead)
and loxP sites (grey arrowhead). The location of SLK primers are indicated in the Flp-recombined and Cre-recombined alleles. b PCR genotyping
of genomic DNA from ear clips for the SLK +/+, SLK +/fl, and SLK fl/fl alleles using 3′F and 3′R primers. c Genomic DNA PCR on the heart and skeletal
muscle from wild type and knockout mice using the three SLK primers. Recombination product is only observed following Cre-mediated
deletion (500 bp). The 3′F and 3′R primers detect non-recombined DNA strand (471 bp). The 5′F and 3′R only generate a product following
recombination, whereas the non-recombined allele (>5 Kbp) could not be amplified by the 5′F and 3′R primers. d Western blot on adult
skeletal muscle lysates from wild type and knockout mice. The membrane was probed with an anti-SLK and anti-GAPDH as a loading control. SLK staining
on TA muscles from e wild type and f knockout mice. Prominent staining in fibers from wild type (indicated with white arrows) which is not present in
knockout. gWestern blot analysis of SLK expression in primary cultures of Myf5-Cre:SLKfl/fl myoblasts showing a marked reduction in SLK levels. h Total
levels of SLK protein within different tissues showing lower expression in normal skeletal muscles
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in body mass was observed in younger mice. This
difference did not persist beyond 20 weeks of age
(Additional file 2: Figure S1A). Otherwise, knockout
mice were apparently normal with no obvious anomalies or
behavioral changes upon weaning. Presence of the loxP site
was confirmed using a forward and reverse primer flanking
the 3′ loxP insertion site (Fig. 1b). Muscle-specific deletion
of SLK was confirmed by isolating DNA from various
skeletal muscle groups, as well as non-myogenic tissue,
from adult animals and conducting PCR analysis to assess
recombination. As expected, the recombined PCR product
was only detected in skeletal muscles from Myf5-Cre:SLKfl/
fl knockout mice (Fig. 1c). The weak positive signal from
the wild type allele is likely due to amplification from con-
taminating non-muscle DNA as observed for other skeletal
muscle-specific knockout studies [8]. Western blot analysis
showed a ~80% decrease in total SLK protein levels in skel-
etal muscle tissues isolated from the knockout mice. This is
similar to decrease previously reported for other Myf5-Cre
carrying mice, as well as other muscle-specific conditional
knockouts (Fig. 1d) [48, 49]. Supporting this, staining for
SLK in wild type fibers showed a strong signal within a sub-
set of myofibers that was absent in knockout muscles
(Fig. 1e, f). Positive staining was observed between fibers
in knockout muscle, likely representing non-myogeniccells expressing SLK [22, 24, 25]. In addition, Western blot
analysis of Myf5-Cre:SLKfl/fl primary cultures showed a
>90% reduction in total SLK levels, suggesting efficient
excision of floxed allele. Interestingly, we observed that
SLK levels are relatively low in muscle tissues (Fig. 1g)
resulting in higher apparent residual SLK levels. Together,
these data suggest that the deletion of SLK is efficient
and robust in the skeletal muscles of adult mice.
To assess the effect of SLK deletion on muscle devel-
opment, Myf5-Cre:SLKfl/fl mice were crossed with the
Rosa26R-LacZ reporter mice and embryos were col-
lected at E12.5. LacZ histochemistry showed that SLK
deletion did not affect the spatiotemporal development
of the myogenic compartments of the limbs or trunk
(Fig. 2a, b). Similarly, staining for MyHC revealed no
obvious differences in the distribution of muscle tissue
in the embryos at this stage of development (Fig. 2c, d).
Together, these results suggest that SLK is dispensable
for embryonic myogenesis.
SLK was previously demonstrated to be expressed pre-
dominantly within type 1 and type 2A fibers [23]. Sur-
prisingly, analysis of fiber type distribution and size did
not differ significantly between 12-week-old wild type
and knockout mice (Fig. 2e–j), suggesting that the loss
of SLK does not significantly impair postnatal skeletal
muscle development or fiber type specification.
Fig. 2 SLK deletion does not affect muscle development. a, b β-galactosidase histochemistry on cross sections of E12.5 embryos from a wild type
(WT) and SLK-null (KO) embryo into the ROSA26R background. The location of neural tube is indicated by an asterisk. c, d MyHC immunofluorescence
staining to identify differentiated skeletal muscle tissue within developing E12.5 embryos. The neural tube is indicated by an asterisk. e, f MyHC type I
staining on soleus muscles (12 weeks) from wild type (WT) and knockout mice (KO). g Minimum Feret’s diameter of type I fibers from each
group (n = 5/genotype). h, i MyHC type II staining and j Minimum Feret’s diameter of type II fibers (n = 5/genotype)
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reduced force generation
To study the effects of SLK deficiency on muscle function
and myofiber morphology, we analyzed skeletal muscles
from 3- to 6-month-old Myf5-Cre:SLKfl/fl knockout mice.
Hematoxylin and eosin staining revealed no significant dif-
ferences between wild type and knockout skeletal muscle in
3-month-old animals (Fig. 3a, b). Surprisingly, the propor-
tion of central nuclei was increased to 8% in 6-month-old
knockout mice, while wild type muscles displayed values
closer to 1%(Fig. 3c, d). Central nuclei appeared throughout
the muscle tissue in different muscle groups, including the
TA, EDL, soleus, and diaphragm. These findings suggestthat the deletion of SLK may impair the integrity of the
myofibers resulting in the activation of a regenerative
response in the skeletal muscles of knockout mice. Sup-
porting this, analysis of myofiber diameter at 6 months of
age showed a small, but significant, reduction in caliber
size in SLK-deficient muscles compared to wild type mice,
suggesting the possible onset of an atrophy phenotype
following SLK deletion (Additional file 2: Figure S1B).
Further analysis by electron microscopy showed intact
sarcomeres in wild type TA muscles, but swollen and
degenerating mitochondria were observed sporadically
throughout the skeletal muscles of knockout mice
(Fig. 3e, f). Interestingly, similar mitochondrial defects
Fig. 3 SLK knockout muscles develop central nuclei and decreased force generation. Hematoxylin and eosin staining on 12-week (a, b) and 24-week
(c, d) animals from each genotype. A high proportion of central nuclei (arrow) appeared in numerous sections from SLK-null mice (8% of total nuclei).
e, f Electron photomicrographs from 24-week-old skeletal muscles showing enlarged and degenerating mitochondria (asterisk). g Western blot analysis
of 24-week-old skeletal muscles reveals increased levels of active p38. The Soleus (h) and EDL (i) muscle fibers were subjected to force measurement
assays (7 wild types, 10 knockouts). Maximal specific force was significantly decreased in knockout muscles
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degeneration [50]. SLK-null skeletal muscles also presented
with increased p38 activity, suggesting the activation of
stress response pathways (Fig. 3g). Activation of p38 has
also been observed in models of muscular dystrophy, sup-
porting the notion that its activity is due to a defect in
myofiber integrity [51]. Mitochondria swelling and degen-
eration has also been previously associated with constitu-
tive activation of MKK6, a regulator of p38 activity and a
marker of increased cellular stress. JNK activity was also
assessed, but no obvious increase was observed (Fig. 3g).
Central nuclear myopathies and skeletal muscle stress
are commonly associated with a decrease in force gener-
ation. Therefore, in order to determine the effect of SLK
deletion on muscle physiology, we performed isometric
force measurements on isolated EDL and soleus fibers
from 3-month-old wild type and knockout mice. As
expected, the soleus muscle, composed of primarily type 1
fibers, had a 36.7% reduction in the total force generated
(Fig. 3h). The EDL, composed of mostly type 2 fast-twitch
fibers, also had a significant decline of 24% in force gener-
ation (Fig. 3i). Together, these results strongly support a
role for SLK in skeletal muscle function and the integrity
of the contractile apparatus.
Consistent damage to myofibers and decreased force
generation is often associated with muscle wasting and
fibrosis, as is the case in animal models of muscular dys-
trophy [52]. However, the levels of periostin and active
GSK3β, markers of fibrosis and atrophy respectively, didnot change significantly between wild type and knockout
mice (Additional file 2: Figure S1C). Furthermore, there
was no increased deposition of collagen in knockout
muscles as detected by Masson’s trichrome staining
(Additional file 2: Figure S1D & E).
Altered localization of focal adhesion proteins in SLK-null
skeletal muscle
SLK has been previously demonstrated to play a role
downstream of FAK in mediating cellular migration [28].
Furthermore, direct phosphorylation of paxillin by SLK is
essential for efficient focal adhesion turnover and cell
motility in fibroblasts [29]. Interestingly, the integrin/FAK
signaling axis also plays an essential role in the formation
of the costamere and in the maintenance of myofiber
integrity [15]. Therefore, to investigate the effect of SLK
deletion on costamere or sarcomere morphology, we
performed immunostaining on cross sections of skeletal
muscles from wild type and knockout mice. Immunofluor-
escence analysis showed that the distribution of dys-
trophin and laminin was unaffected by the loss of SLK on
skeletal muscle cross sections (Fig. 4a, c, e, g). Similarly,
no differences were observed on longitudinal sections,
suggesting that the components of the DGC were not
affected by the deletion of SLK (Fig. 4b, d, f, h). Total
levels of dystrophin also remained unchanged, as observed
by Q-PCR (Additional file 3: Figure S2A).
Because SLK was previously shown to play a role in
cell migration downstream of FAK/Src signaling, the
Fig. 4 The dystrophin and laminin patterns are unaffected in SLK-null muscles. Dystrophin (a, b, e, f) and laminin (c, d, g, h) immunostaining on
24-week-old TA muscle from wild type and knockout mice. No apparent differences observed between the groups on either cross or longitudinal sections
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bers was also assessed. Similar to dystrophin and laminin,
the staining pattern of vinculin was unaffected following
SLK deletion (Fig. 5a, d). Interestingly, paxillin localization
was predominantly found within the myofibers of SLK-
deficient skeletal muscle, whereas wild type controls
showed distinct peripheral staining (Fig. 5b, e). Add-
itionally, FAK localization was altered in a similar
pattern with a “patchy” distribution throughout the
myofibers (Fig. 5c, f ). Further analysis of paxillin distri-
bution by confocal microscopy on isolated myofibers
showed a similar mislocalization pattern in knockout
fibers (Fig. 5h–j). Focal adhesion components have been
shown to be critical for myotendinous junction function
[17, 18, 48]. The mislocalization of paxillin and FAK inFig. 5 Altered paxillin and FAK distribution in SLK-deficient muscles. a, d V
knockout fibers in TA muscles. However, paxillin (b, e) was readily detectab
pattern in knockouts. c, f FAK localization was also severely disrupted in kn
underneath the membrane. g Western blot analysis for markers of the foca
either FAK or Paxillin. h Illustration of myofibers showing viewpoints of con
knockout fibersSLK-deficient muscles strongly suggests a defect in the
organization of the myotendinous junction, a critical
mediator of myofiber stabilization. Activation status of
both FAK and paxillin was highly variable in both wild
type and knockout muscles. However, quantitation and
normalization to total FAK or paxillin did show any differ-
ences between the genotypes (data not shown and Fig. 5g).
Taken together, our data suggest that the myopathy
observed in the SLK-deficient muscles is due in part to
underlying defects in the costamere or sarcomere
organization due to altered localization of components of
the focal adhesion complex. As loss of α7β1 integrins
show similar muscle phenotypes as SLK deficiency [8–10],
we assessed the levels of these integrins in muscles from
both genotypes by Q-PCR. However, no changes wereinculin immunostaining remained unchanged between wild type and
le at the periphery of wild-type myofibers but displayed a cytosolic
ockout fibers with no cytoplasmic staining and strong positive clusters
l adhesion complex showed no differences in the activation status of
focal images. i, j Confocal image of paxillin staining in wild type and
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itional file 3: Figure S2B–D).
Muscle regeneration is delayed in SLK-null myofibers
Previously, we reported that the expression of a truncated
dominant negative SLK construct reduced the fusion
capacity of C2C12 myoblasts [23]. Therefore, we initially
assessed the differentiation potential of SLK-deficient myo-
blasts. Primary myoblast cultures were derived from SLKfl/fl
mice and infected with Ad-LacZ control adenovirus or
Ad-Cre in order to delete SLK. Compared to Ad-LacZ in-
fected controls, SLK-deleted myoblasts had a lower fusion
capacity, reduced from 60% in the wild type to 15% in theFig. 6 SLK-deficient muscles display a delayed regenerative response. Prim
AdCre and then differentiated. After 4 days, the cultures were stained with
(AdLacZ 45.1%, AdCre 10.7%, p < 0.01). e–j The TA muscles of 10–12-week-
assessed by measuring fiber area. SLK-deficient mice showed a reduction in
21 days, suggesting a delayed response (n = 5/genotype). Seven-day regen
in Pax7+ or Myf5+ nuclei were observed between the groups (n = 3/genotknockout, but still retained the expression of differenti-
ation markers such as MyHC and MyoG (Fig. 6a–d).
Muscle regeneration proceeds through the activation
and proliferation of satellite cells that acquire Myf5
expression rapidly following their activation [43]. To in-
vestigate the role of SLK in muscle repair, we performed
cardiotoxin injections into the TA muscle of wild type
and knockout mice. Muscle sections were collected at 7
and 21 days post injection (DPI), and the cross-sectional
area of the myofibers was measured. Regenerating SLK-
deficient muscles displayed a decreased fiber size at
7 DPI compared to knockout animals (Fig. 6e–g). How-
ever, fiber sizes of knockout mice where comparable toary myoblasts isolated from SLKfl/fl mice were treated with AdLacz or
MF-20 (a, b) or Myogenin (c, d) and myoblast fusion was assessed
old mice were injected with cardiotoxin and muscle regeneration was
caliber size 7 days post-injection that was no longer apparent at
erates were also stained for Pax7 (k–m) and Myf5 (m–p). No changes
ype)
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the loss of SLK delays but does not completely block the
regenerative process (Fig. 6h–j). Analysis of the myo-
genic lineages in regenerating muscles revealed that the
number of Myf5+ and Pax7+ cells were similar in wild
type and knockout muscles, suggesting that the activa-
tion and expansion of satellite cells proceeded normally
in SLK-null muscles (Fig. 6k–p). Together, these data
show that the loss of SLK impairs myoblast fusion
in vitro but only results in a delay in regeneration with-
out any apparent long-term regenerative defects in vivo.
Discussion
Our data show that mice lacking SLK in skeletal muscles
are viable and fertile but present with a progressive central
nuclear myopathy and muscle weakness that is readily
apparent as early as 3 months of age. In addition, we show
that SLK plays a role in the structural integrity of the myo-
fibers and is necessary for maximal force generation. Dele-
tion of SLK from the myofibers resulted in altered
localization of proteins of the focal adhesion complex,
likely contributing to myofiber instability. Overall, these
observations suggest that SLK is dispensable for muscle
development and regeneration but is critical to the integ-
rity and the structural organization of the myofibers.
Previously, we have shown that the expression of a
dominant negative SLK construct in C2C12 myoblasts
blocked fusion and inhibited terminal differentiation.
Consistent with this, primary myoblasts deficient in SLK
also had a significant reduction in their fusion index.
Surprisingly, the deletion of SLK in myoblasts in vivo
did not result in a severe impairment of muscle regener-
ation. Furthermore, SLK-deficient muscles appear to form
normally during embryonic myogenesis, indicating that
myoblast fusion in embryonic myoblasts is unaffected by
SLK deletion. These findings are similar to what has been
observed for PKC-θ [53]. Indeed, PKC-θ has been shown
to regulate myoblast fusion through upregulation of β-
integrin D and caveolin-3 by a FAK-dependent mechanism.
The PKC-θ-null mouse is viable, suggesting that myoblasts
may activate a compensatory mechanism in vivo, allowing
for efficient embryonic development and muscle repair.
Similar to the deletion of SLK, PKC-θ-null mice had a
reduced body mass upon weaning and presented with a
mild muscle wasting phenotype, suggesting that PKC-θ is
required for proper muscle development and stability. One
possibility is that critical differences in extracellular stimuli
are likely to prevent the activation of these compensatory
pathways in vitro. Similarly, the deletion of FAK in culture
prevented myoblast fusion in vitro, but only caused a delay
in muscle repair in vivo [20]. The in vivo and in vitro differ-
ences shared between the SLK, FAK, and PKC-θ-null mice
highlight the existence of important compensatory path-
ways that cannot be activated in vitro.The molecular mechanisms of SLK signaling have been
predominantly studied in fibroblast cell lines. In these
cells, a role for SLK at the leading edge of migrating cells
has been established. SLK has been shown to be activated
downstream of FAK and Src signaling and to play a role in
cell migration following scratch wounding in vitro. In
addition, SLK has been demonstrated to phosphorylate
the adapter paxillin to induce focal adhesion turnover, a
process necessary for cell motility. This is of particular
importance in developing myofibers as the components of
the focal adhesion complex play a pivotal role not only in
myoblast fusion but also in the development and integrity
of the costameres and attachment at the MTJ. Costameres
are active sites for signaling and sarcomere attachment to
the ECM. Deletion or mutations in costamere-associated
proteins result in an increase in central nuclei, decreased
force generation and, in some cases, lethality. Our studies
show that SLK-deficient muscles display altered localization
of FAK and paxillin, two important costamere proteins.
Interestingly, vinculin localization was not affected,
suggesting that SLK deletion might affect a subset of
costameric proteins. Nevertheless, this is likely to affect
costameric signaling and to result in weaker attachment of
the MTJ and the sarcomere. Based on our findings, SLK
appears to be a regulator of myofiber integrity and stabil-
ity. However, the phenotype observed the following SLK
deletion was much less severe than for other cytoskeletal
regulators such as Talin and ILK [17, 18, 48, 54]. This may
be in part due to compensation from an alternative
pathway that remains to be uncovered. Nevertheless, SLK
deficiency results in similar mislocalization of focal adhe-
sion proteins within the myofiber.
We have previously reported that muscle-specific overex-
pression of a dominant negative SLK from the human
skeletal actin promoter (HSA-SLKK63R) results in enhanced
muscle regeneration as well as an increase in the fusion
index of primary myoblasts [36]. Furthermore, expression
of HSA-SLKK63R also affected muscle organization during
development with a marked reduction in litter sizes. Since
Pax7+ satellite cells arise from embryonic myoblasts, most
of which express Myf5 during development, the Myf5-Cre
model would mediate deletion of SLK during early embryo-
genesis and in adult satellite cells. Surprisingly, deletion of
SLK had no apparent effect on embryonic development but
caused a delay in muscle regeneration following cardiotoxin
induce injury. However, SLK deletion significantly reduced
primary myoblast fusion in vitro. One likely possibility is
that SLK plays kinase-dependent and -independent roles
during the differentiation and the maturation process. The
expression of a full-length kinase dead SLK in differen-
tiating cells would still allow its scaffolding functions in
the HSA-K63R model. The activation of kinase-dependent
pathways would be impaired, leading to the developmental
delay previously observed [36]. However, in the SLK-null
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would be impaired during development and repair. The
loss of scaffolding functions in the SLK-null muscles likely
leads to anchoring defects of focal adhesion proteins, as
these were not observed in the HSA-K63R model. These
findings may also explain why known downstream targets
of SLK, such as JNK-1 and RhoA, remained unchanged in
knockout skeletal muscle (data not shown). The observed
differences in regenerative phenotype between the two
models could also be due in part to the use of distinct
genetic promoters. The Myf5 gene is highly expressed
following the activation of satellite cells and remains high
in proliferating myoblasts. Conversely, the HSA promoter
is active upon cell cycle withdrawal. This supports a role
for SLK during myoblast proliferation and fusion and
would suggest that its activity needs to be downregulated in
order to facilitate myoblast differentiation. Employing the
use of the HSA-Cre and the conditional SLK knockout
allele may be useful in order to reconcile these phenotypes.
We have previously shown a role for SLK in cell cycle
progression through G2/M [31]. Interestingly, we have
also observed a decrease in SLK activity prior to myoblast
fusion, suggesting that downregulation of SLK activity
may be necessary for cell cycle exit and differentiation
[23]. The observed regenerative phenotype observed in
our knockout mice may reflect a short delay in the expan-
sion of the myoblast population following satellite cell
activation, as SLK has been demonstrated to be a mediator
of cellular proliferation.
We and others have uncovered a number of substrates
for SLK. Phosphorylation of paxillin by SLK was shown to
be critical for optimal migration of mouse embryonic
fibroblasts [29]. Additionally, RhoA has been identified as
an SLK target in smooth muscle cells [30]. ASK1 was
shown to be regulated by SLK, providing a link between
SLK activity and p38/JNK-1 activation [55]. However,
assessment of these pathways did not yield any insight as
to the molecular mechanisms by which SLK controls
myofiber integrity. Assessments of p38 activity in our
model conflicted with previously published data in which
SLK phosphorylation of ASK1 was postulated to activate
ASK1, resulting in subsequent activation of p38. However,
p38 activity was drastically increased in SLK-null skeletal
muscle, suggesting alternative SLK-independent regulation
of this pathway in skeletal muscle. Alternatively, increased
p38 activity could reflect the activation of a stress
response induced by the loss of myofiber integrity. The
identification of muscle-specific substrates for SLK will
undoubtedly provide insights into the role of this kinase in
developing muscles and mature myofibers.
Conclusions
Overall, our data show that deletion of SLK in myogenic
precursors did not overtly affect muscle development butinduced a mild myopathy that was readily apparent in older
mice. Activation of the stress response pathways and
decreased force generation suggest that the deletion of SLK
impairs myofiber stability. This decreased functionality is
due in part to mislocalization of adhesion proteins at the
MTJ. These results suggest that SLK is dispensable for
muscle regeneration and development but is required for
the stability of myotendinous junctions and overall muscle
integrity.
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